These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 18178378)
1. Monosodium glutamate (MSG): a villain and promoter of liver inflammation and dysplasia. Nakanishi Y; Tsuneyama K; Fujimoto M; Salunga TL; Nomoto K; An JL; Takano Y; Iizuka S; Nagata M; Suzuki W; Shimada T; Aburada M; Nakano M; Selmi C; Gershwin ME J Autoimmun; 2008; 30(1-2):42-50. PubMed ID: 18178378 [TBL] [Abstract][Full Text] [Related]
2. Neonatal monosodium glutamate treatment causes obesity, diabetes, and macrovesicular steatohepatitis with liver nodules in DIAR mice. Tsuneyama K; Nishida T; Baba H; Taira S; Fujimoto M; Nomoto K; Hayashi S; Miwa S; Nakajima T; Sutoh M; Oda E; Hokao R; Imura J J Gastroenterol Hepatol; 2014 Sep; 29(9):1736-43. PubMed ID: 24730643 [TBL] [Abstract][Full Text] [Related]
3. Effects of bezafibrate in nonalcoholic steatohepatitis model mice with monosodium glutamate-induced metabolic syndrome. Sasaki Y; Shimada T; Iizuka S; Suzuki W; Makihara H; Teraoka R; Tsuneyama K; Hokao R; Aburada M Eur J Pharmacol; 2011 Jul; 662(1-3):1-8. PubMed ID: 21549692 [TBL] [Abstract][Full Text] [Related]
4. Dose dependent development of diabetes mellitus and non-alcoholic steatohepatitis in monosodium glutamate-induced obese mice. Sasaki Y; Suzuki W; Shimada T; Iizuka S; Nakamura S; Nagata M; Fujimoto M; Tsuneyama K; Hokao R; Miyamoto K; Aburada M Life Sci; 2009 Sep; 85(13-14):490-8. PubMed ID: 19683013 [TBL] [Abstract][Full Text] [Related]
5. A dietary restriction influences the progression but not the initiation of MSG-Induced nonalcoholic steatohepatitis. Fujimoto M; Tsuneyama K; Nakanishi Y; Salunga TL; Nomoto K; Sasaki Y; Iizuka S; Nagata M; Suzuki W; Shimada T; Aburada M; Shimada Y; Gershwin ME; Selmi C J Med Food; 2014 Mar; 17(3):374-83. PubMed ID: 24588719 [TBL] [Abstract][Full Text] [Related]
6. Monosodium glutamate neonatal intoxication associated with obesity in adult stage is characterized by chronic inflammation and increased mRNA expression of peroxisome proliferator-activated receptors in mice. Roman-Ramos R; Almanza-Perez JC; Garcia-Macedo R; Blancas-Flores G; Fortis-Barrera A; Jasso EI; Garcia-Lorenzana M; Campos-Sepulveda AE; Cruz M; Alarcon-Aguilar FJ Basic Clin Pharmacol Toxicol; 2011 Jun; 108(6):406-13. PubMed ID: 21205225 [TBL] [Abstract][Full Text] [Related]
7. Early onset and progression of non-alcoholic fatty liver disease in young monosodium l-glutamate-induced obese mice. Coelho CFF; França LM; Nascimento JR; Dos Santos AM; Azevedo-Santos APS; Nascimento FRF; Paes AMA J Dev Orig Health Dis; 2019 Apr; 10(2):188-195. PubMed ID: 29855396 [TBL] [Abstract][Full Text] [Related]
14. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis. Witek RP; Stone WC; Karaca FG; Syn WK; Pereira TA; Agboola KM; Omenetti A; Jung Y; Teaberry V; Choi SS; Guy CD; Pollard J; Charlton P; Diehl AM Hepatology; 2009 Nov; 50(5):1421-30. PubMed ID: 19676126 [TBL] [Abstract][Full Text] [Related]
15. Monosodium Glutamate (MSG)-Induced Animal Model of Type 2 Diabetes. Bahadoran Z; Mirmiran P; Ghasemi A Methods Mol Biol; 2019; 1916():49-65. PubMed ID: 30535681 [TBL] [Abstract][Full Text] [Related]
16. Subcutaneous administration of monosodium glutamate to pregnant mice reduces weight gain in pups during lactation. Park JH; Choi TS Lab Anim; 2016 Apr; 50(2):94-9. PubMed ID: 26043886 [TBL] [Abstract][Full Text] [Related]
17. Long-term ingestion of monosodium L-glutamate did not induce obesity, dyslipidemia or insulin resistance: a two-generation study in mice. Nakamura H; Kawamata Y; Kuwahara T; Smriga M; Sakai R J Nutr Sci Vitaminol (Tokyo); 2013; 59(2):129-35. PubMed ID: 23727643 [TBL] [Abstract][Full Text] [Related]
18. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease. Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634 [TBL] [Abstract][Full Text] [Related]
19. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. McCullough AJ Clin Liver Dis; 2004 Aug; 8(3):521-33, viii. PubMed ID: 15331061 [TBL] [Abstract][Full Text] [Related]
20. High-fat emulsion-induced rat model of nonalcoholic steatohepatitis. Zou Y; Li J; Lu C; Wang J; Ge J; Huang Y; Zhang L; Wang Y Life Sci; 2006 Aug; 79(11):1100-7. PubMed ID: 16624332 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]